Your browser doesn't support javascript.
loading
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma.
Kim, Hyera; Jeong, Hyehyun; Yamaguchi, Motoko; Sohn, Insuk; Yoon, Sang Eun; Byeon, Seonggyu; Hur, Joon Young; Koh, Youngil; Yoon, Sung-Soo; Kim, Eo Jin; Oguchi, Masahiko; Miyazaki, Kana; Taguchi, Senzo; Yoon, Dok Hyun; Cho, Junhun; Ko, Young Hyeh; Kim, Seok Jin; Suzuki, Ritsuro; Kim, Won Seog.
Affiliation
  • Kim H; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Jeong H; Division of Hematology-Oncology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, South Korea.
  • Yamaguchi M; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Sohn I; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
  • Yoon SE; Statistics and Data Center, Samsung Medical Center, Seoul, South Korea.
  • Byeon S; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Hur JY; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Koh Y; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Yoon SS; Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Guri Hospital, Guri, South Korea.
  • Kim EJ; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Oguchi M; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Miyazaki K; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Taguchi S; Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yoon DH; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
  • Cho J; Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ko YH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim SJ; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; and.
  • Suzuki R; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; and.
  • Kim WS; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Blood ; 136(22): 2548-2556, 2020 11 26.
Article de En | MEDLINE | ID: mdl-32584959

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Méthotrexate / Tumeurs du système nerveux central / Lymphome T-NK extraganglionnaire / Modèles biologiques Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Blood Année: 2020 Type de document: Article Pays d'affiliation: Corée du Sud

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Méthotrexate / Tumeurs du système nerveux central / Lymphome T-NK extraganglionnaire / Modèles biologiques Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Blood Année: 2020 Type de document: Article Pays d'affiliation: Corée du Sud